Serotype distribution, antimicrobial susceptibility and molecular epidemiology of invasive Streptococcus pneumoniae in the nine-year period in Serbia
- PMID: 37670985
- PMCID: PMC10475725
- DOI: 10.3389/fmicb.2023.1244366
Serotype distribution, antimicrobial susceptibility and molecular epidemiology of invasive Streptococcus pneumoniae in the nine-year period in Serbia
Abstract
Streptococcus pneumoniae is one of the leading bacterial pathogens that can cause severe invasive diseases. The aim of the study was to characterize invasive isolates of S. pneumoniae obtained during the nine-year period in Serbia before the introduction of the pneumococcal conjugate vaccines (PCVs) into routine vaccination programs by determining: serotype distribution, the prevalence and genetic basis of antimicrobial resistance, and genetic relatedness of the circulating pneumococcal clones. A total of 490 invasive S. pneumoniae isolates were included in this study. The serotype, antimicrobial susceptibility, and ST of the strains were determined by the Quellung reaction, disk- and gradient-diffusion methods, and multilocus sequence typing (MLST), respectively. The most common serotypes in this study were 3, 19F, 14, 6B, 6A, 19A, and 23F. The serotype coverages of PCV10 and PCV13 in children less than 2 years were 71.3 and 86.1%, respectively, while PPV23 coverage in adults was in the range of 85-96%, depending on the age group. Penicillin and ceftriaxone-non-susceptible isolates account for 47.6 and 16.5% of all isolates, respectively. Macrolide non-susceptibility was detected in 40.4% of isolates, while the rate of multidrug- and extensive-drug resistance was 20.0 and 16.9%, respectively. The MLST analysis of 158 pneumococci identified 60 different STs belonging to the 16 Clonal Complexes (CCs) (consisting of 42 STs) and 18 singletons. The most common CC/ST were ST1377, CC320, CC15, CC273, CC156, CC473, CC81, and CC180. Results obtained in this study indicate that the pre-vaccine pneumococcal population in Serbia is characterized by high penicillin and macrolides non-susceptibility, worrisome rates of MDR and XDR, as well as a high degree of genetic diversity. These findings provide a basis for further investigation of the changes in serotypes and genotypes that can be expected after the routine introduction of PCVs.
Keywords: Serbia; Streptococcus pneumoniae; antimicrobial susceptibility; molecular epidemiology; serotype.
Copyright © 2023 Opavski, Jovicevic, Kabic, Kekic, Vasiljevic, Tosic, Medic, Laban, Ranin and Gajic.
Conflict of interest statement
NO acts as a principal investigator for investigator-initiated sponsored research related to the topic conducted on behalf of the Faculty of Medicine, University of Belgrade, for which the Faculty obtained a research grant from Merck Sharp and Dohme doo. There are no patents, products in development, or marketed products associated with this research. We fully adhere to Frontiers policies on data and material sharing. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Figures
References
-
- Brueggemann A. B., Griffiths D. T., Meats E., Peto T., Crook D. W., Spratt B. G. (2003). Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J. Infect. Dis. 187, 1424–1432. doi: 10.1086/374624 - DOI - PubMed
-
- CDC . (2019). Pneumococcal disease surveillance reporting and trends | CDC. Available at: https://www.cdc.gov/pneumococcal/surveillance.html (Accessed May 30, 2023).
-
- CDC . (2020). Global pneumococcal disease and vaccination | CDC. Available at: https://www.cdc.gov/pneumococcal/global.html#vaccines (Accessed May 30, 2023).
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
